查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
美国生理食盐水市场规模和预测、区域份额、趋势和成长机会分析报告范围：按类型、包装类型、应用、给药途径和最终用户
市场调查报告书
商品编码
1424144

美国生理食盐水市场规模和预测、区域份额、趋势和成长机会分析报告范围：按类型、包装类型、应用、给药途径和最终用户

US Physiological Saline Market Size and Forecasts, Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Packaging Type, Application, Route of Administration, and End User
出版日期: | 出版商: The Insight Partners | 英文 132 Pages | 订单完成后即时交付

价格

2022年生理食盐水市场价值为24.12亿美元，预计到2030年将达到39.10亿美元；预计2022年至2030年CAGR为6.2%。严重疾病、液体电解质失衡的盛行率上升以及老年人口对液体电解质的需求激增是导致生理食盐水市场规模不断增长的因素之一。然而，快速等渗盐水输注的不利影响阻碍了生理食盐水市场的成长。

生理食盐水溶液由具有相同pH值的等渗盐溶液组成。生理食盐水溶液的例子是林格氏溶液，由氯化钠(NaCl)、碳酸氢钠和氯化钾溶液组成。医生建议在患者出现脱水、液体失衡和更多临床异常的情况下使用生理解决方案。

市场机会

使用低成本盐溶液快速运送样品

一种更便宜且容易获得的盐溶液可以运输测试样本，从而能够更有效、安全、长距离地将样本运送到诊断实验室。一种现成的盐溶液，如“磷酸盐缓衝盐水”，一种医院和临床实验室常见的简单盐溶液，被用作冠状病毒污染标本的运输介质；盐水可使样品保持稳定长达 18 小时。在 COVID-19 大流行期间，病毒运输介质的短缺给将从 COVID-19 患者身上获取的标本运输到诊断和测试实验室带来了重大挑战，导致对无菌盐溶液的需求激增。因此，研究人员建议使用廉价且常见的盐溶液（例如磷酸盐缓衝盐溶液）进行运输。因此，人们对更便宜、更容易获得的盐溶液及其在运输医学标本中的使用的认识不断提高，可能会在 2022-2030 年期间为美国生理盐水市场提供机会。

細項分析

基于类型的见解

依类型划分，美国生理食盐水市场分为生理食盐水、高渗透压盐水、低渗透压盐水和平衡盐水。生理食盐水细分市场在 2022 年占据最大的市场份额，预计该细分市场在 2022 年至 2030 年期间CAGR最高。生理食盐水 (NS) 是一种无菌盐溶液，用于短期补液，因为它有助于恢復体内的电解质/盐水平。它是一种 0.9% 的氯化钠溶液，旨在治疗人们的脱水和电解质失衡。 NS 是临床上常用的静脉注射液的基石。它适用于儿童和成人患者群体。使用经美国食品药物管理局 (FDA) 批准的 NS 溶液的主要适应症如下：

细胞外液补充治疗脱水、低血容、出血、败血症等。

存在体液流失的代谢性碱中毒的治疗

轻度钠缺乏

此外，NS只能透过静脉注射给药，生理食盐水管理需要评估患者的健康状况。药剂师需要监控静脉输液的实施情况，同时根据患者的临床情况安装和建议订单，并就剂量和给药方面向医院护理部门提供适当的咨询。

基于包装类型的见解

美国生理食盐水市场依包装类型分为软袋、塑胶瓶和玻璃瓶。塑胶瓶细分市场将在 2022 年占据更大的市场份额，预计软袋细分市场在预测期内的CAGR最高。注射用氯化钠 (NaCl) USP 溶液是无菌且无热原的。它们是注射用水 (WFI) 中含有不同浓度 NaCl 的肠胃外溶液，用于静脉 (IV) 给药。此外，柔性容器由特殊配方的聚氯乙烯製成。然而，与塑胶容器接触的溶液可能会从塑胶中滤出极少量的某些化学成分。此外，生物测试证明可以有效支持塑胶容器材料的安全性。因此，在预测期内，塑胶瓶预计将占生理食盐水市场的最小份额。

基于应用程式的见解

依应用划分，美国生理食盐水市场分为静脉注射、眼科、伤口照护、内视镜检查、皮肤擦伤等。静脉注射细分市场在 2022 年占据更大的市场份额，预计该细分市场在预测期内复合CAGR最高。配製静脉 (IV) 盐水溶液以预防或治疗脱水。所有年龄层的医生都会为受伤、生病、脱水或接受手术的人开静脉注射生理食盐水。盐水静脉注射袋提供快速、有针对性的解决方案来补充液体和缓解症状。

此外，无菌水和氯化钠或盐和生理食盐水静脉注射的组合有助于恢復患者的体液平衡和水合组织。当患者需要水合作用时，通常会在患者的血液中註入静脉注射盐水。它适合对特定药物过敏或敏感的人。

多家公司正在生产与静脉注射盐水相关的创新产品；例如，Fresenius Kabi USA 提供“freeflex”和“freeflex+ IV 袋”。这些产品还提供防漏、无菌保护和防针刺伤功能。

基于管理的洞察之路

美国生理食盐水市场依给药途径分为静脉注射和局部注射。静脉注射细分市场在 2022 年占据更大的市场份额，预计该细分市场在预测期内复合CAGR最高。静脉注射盐水溶液是专门配製的液体，注射静脉以预防和治疗脱水。此外，这些静脉输液适用于所有患有疾病、受伤、脱水等的年龄层的人。静脉注射生理食盐水是一种简单、安全、常见的手术，併发症风险较低。此外，液体復苏是治疗急诊患者的重要组成部分，生理食盐水被认为是重症或受伤患者最广泛使用的静脉输液。作为一种常见、简单且安全的手术，透过静脉注射途径给药的患者可能会很快感到缓解。

目录

第 1 章：简介 13

  • Insight Partners 研究报告指南。 13
  • 市场区隔. 14

第 2 章：执行摘要 16

第 3 章：研究方法 17

  • 覆盖范围。 19
  • 二次研究。 19
  • 初步研究。 20

第 4 章：美国生理食盐水市场格局 21

  • 概述。 21
  • PEST 分析。 22
    • 美国 PEST 分析。 22
  • 供应链分析。 22

第 5 章：美国生理食盐水市场 - 主要产业动态 25

  • 主要市场驱动因素。 26
    • 严重疾病和液体电解质失衡的盛行率不断上升。 26
  • 人口老化对液体电解质的需求激增。 26
  • 主要市场限制：27
    • 快速等渗盐水输注的不良反应。 27
  • 主要市场机会：27
    • 较便宜的盐溶液可以提高速度和运输 27
  • 未来的趋势。 28
    • 医院环境中的大规模盐溶液需求。 28
  • 影响分析：29

第 6 章：美国生理食盐水市场 - 市场分析 30

  • 美国生理食盐水市场收入，2020 - 2030. 30

第 7 章：美国生理食盐水市场 - 收入和 2030 年预测 - 按类型 32

  • 概述。 32
  • 美国生理食盐水市场收入份额，按类型 2022 年和 2030 年 (%) 32
  • 生理食盐水。 33
  • 高渗盐水。 35
  • 低渗盐水。 37
  • 平衡盐溶液。 39

第 8 章：美国生理食盐水市场 - 2030 年收入和预测 - 按包装类型 41

  • 概述。 41
  • 2022 年及 2030 年美国生理食盐水市场收入份额，依包装类型划分 (%) 41
  • 柔性袋。 42
  • 塑胶瓶。 44
  • 玻璃瓶。 46

第 9 章：美国生理食盐水市场 - 2030 年收入与预测 -按应用48

  • 概述。 48
  • 2022 年及 2030 年美国生理食盐水市场收入份额，依应用划分 (%) 48
  • 静脉。 49
  • 眼科。 51
  • 伤口护理。 53
  • 内视镜检查。 55
  • 皮肤磨损。 56
  • 其他的。 57

第 10 章：美国生理食盐水市场 - 收入和 2030 年预测 - 按给药途径 58

  • 概述。 58
  • 2022 年及 2030 年美国生理食盐水市场收入份额，依给药途径划分 (%) 58
  • 静脉。 59
  • 主题 60

第 11 章：美国生理食盐水市场 - 收入和 2030 年预测 - 按最终用户 62

  • 概述。 62
  • 2022 年及 2030 年美国生理食盐水市场收入份额，依最终用户划分 (%) 62
  • 医院。 63
  • 专科诊所。 64
  • 门诊手术中心。 65
  • 家庭护理。 66
  • 其他的。 67

第 12 章：公司简介

  • Fresenius Kabi AG. 68
  • Merck KGaA. 71
  • AdipoGen Life Sciences Inc. 78
  • Enzo Life Sciences Inc. 83
  • ICU Medical Inc. 88
  • Grifols SA. 94
  • Geno Technology Inc. 101
  • B Braun Medical Inc. 107
  • Pfizer Inc. 113
  • Ward's Science. 119

第13章：附录129

  • 关于我们。 129
  • 专业术语。 131
Product Code: TIPRE00032155

The physiological saline market was valued at US$ 2.412 billion in 2022 and is projected to reach US$ 3.910 billion by 2030; it is estimated to register a CAGR of 6.2% from 2022 to 2030. The rising prevalence of serious illnesses, fluid electrolyte disorders, and surging demand for fluid electrolytes in the elderly population are among the factors contributing to the growing physiological saline market size. However, the adverse effects of rapid isotonic saline infusion hinder the growth of the physiological saline market.

A physiological saline solution is composed of isotonic salt solutions with the same pH. An example of a physiological saline solution is Ringer's solution, composed of sodium chloride (NaCl), sodium bicarbonate, and potassium chloride solution. The physician recommends the physiological solution in case of dehydration, fluid imbalances, and many more clinical abnormalities among the patients.

Market Opportunity

Rapid Sample Transportation Using Low-Cost Saline Solutions

A less expensive and readily available saline solution can transport testing samples, enabling more effective, safe, long-distance transportation of samples to diagnostic labs. A readily available saline solution such as "Phosphate Buffered Saline," a simple salt solution commonly available in hospitals and clinical laboratories, was used as a transport medium for coronavirus-contaminated specimens; the saline could keep the samples stable for up to 18 hours. During the COVID-19 pandemic, a shortage of viral transport media posed a major challenge in transporting specimens obtained from COVID-19 patients to diagnostics and testing labs, resulting in an upsurge in demand for sterile saline solutions. As a result, researchers recommended using inexpensive and commonly available salt solutions, such as phosphate-buffered saline solutions, for transportation. Therefore, the rising awareness of less expensive and readily available saline solutions and their use in transporting medical specimens will likely provide opportunities to the US physiological saline market during 2022-2030.

Segmental Analysis

Type-Based Insights

By type, the US physiological saline market is segmented into normal saline, hypertonic saline, hypotonic saline, and balanced saline. The normal saline segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR during 2022-2030. Normal saline (NS) comprises a sterile salt solution used for short-term fluid replacement, as it helps restore electrolyte/salt levels in the body. It is a 0.9% sodium chloride solution intended to treat dehydration and electrolyte disturbances among people. NS is a cornerstone of intravenous solutions commonly used in clinical settings. It is suitable for both pediatric and adult patient populations. Primary indications for the use of NS solutions that are approved by the Food and Drug Administration (FDA) are as follows:

Extracellular fluid replacement to treat dehydration, hypovolemia, hemorrhage, sepsis, etc.

Treatment of metabolic alkalosis in the presence of fluid loss

Mild sodium depletion

Further, NS can only be administered through intravenous access, and normal saline management requires evaluating the patient's health status. Pharmacists need to monitor the implementation of IV fluids while installing and recommending orders based on the patient's clinical situation with proper counseling to the nursing department in the hospital regarding dosage and administration.

Packaging Type-Based Insights

The US physiological saline market, by packaging type, is segmented into flexible bags, plastic bottles, and glass bottles. The plastic bottles segment held a larger market share in 2022, and the flexible bag segment is anticipated to register the highest CAGR during the forecast period. Sodium chloride (NaCl) USP solutions for injections are sterile and nonpyrogenic. They are parenteral solutions containing various NaCl concentrations in water for injection (WFI) intended for intravenous (IV) administration. Further, the flexible container is fabricated from a specially formulated polyvinyl chloride. However, solutions coming in contact with plastic containers might leach out certain chemical components from the plastic in very small amounts. Further, biological testing proves effective in supporting the safety of plastic container materials. Therefore, the plastic bottles segment is expected to account for the smallest share of the physiological saline market during the forecast period.

Application-Based Insights

By application, the US physiological saline market is segmented as intravenous, ophthalmology, wound care, endoscopy, skin abrasion, and others. The intravenous segment held a larger market share in 2022, and the same segment is anticipated to register the highest CAGR during the forecast period. Intravenous (IV) saline solutions are formulated to prevent or treat dehydration. Physicians of all ages prescribe IV saline for people who are injured, sick, dehydrated, or undergoing surgery. Saline IV bags provide a rapid, targeted solution to replenish fluids and relieve symptoms.

Furthermore, a combination of sterile water and sodium chloride, or salt and normal saline IVs, helps restore fluid balance and hydrate tissues among patients. IV saline is commonly administered to patient's bloodstreams when they require hydration. It is suitable for people with allergies or sensitivities to specific medications.

Various companies are producing innovative products related to IV saline; for example, Fresenius Kabi USA offers "freeflex" and "freeflex+ IV bags." These products also provide leak prevention, sterility protection, and needle-stick prevention.

Route of Administration-Based Insights

The US physiological saline market, by route of administration, is bifurcated into intravenous and topical. The intravenous segment held a larger market share in 2022, and the same segment is anticipated to register the highest CAGR during the forecast period. IV saline solutions are specially formulated liquids that are injected into a vein to prevent and treat dehydration. Also, these IV fluids are utilized among people of all ages suffering from sickness, injury, dehydration, etc. The IV saline solution is a simple, safe, and common procedure with a low risk of complications. Also, fluid resuscitation is a vital component for managing acutely ill patients, and normal saline is considered the most widely used IV fluid for seriously ill or injured patients. Being a common, simple, and safe procedure, patients administered via the IV route may feel relief quickly.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the US physiological saline market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global US physiological saline market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth country market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction 13

  • 1.1 The Insight Partners Research Report Guidance. 13
  • 1.2 Market Segmentation. 14

2. Executive Summary 16

3. Research Methodology 17

  • 3.1 Coverage. 19
  • 3.2 Secondary Research. 19
  • 3.3 Primary Research. 20

4. US Physiological Saline Market Landscape 21

  • 4.1 Overview. 21
  • 4.2 PEST Analysis. 22
    • 4.2.1 US PEST Analysis. 22
  • 4.3 Supply Chain Analysis. 22

5. US Physiological Saline Market - Key Industry Dynamics 25

  • 5.1 Key Market Drivers. 26
    • 5.1.1 Rising Prevalence of Serious Illnesses and Fluid Electrolytes Disorders. 26
  • 5.2 Surging Demand for Fluid Electrolytes in Aging Population. 26
  • 5.3 Key Market Restraints: 27
    • 5.3.1 Adverse Effects of Rapid Isotonic Saline Infusion. 27
  • 5.4 Key Market Opportunities: 27
    • 5.4.1 Less Expensive Saline Solution Can Improve Speed and Transport 27
  • 5.5 Future Trends. 28
    • 5.5.1 Large-Scale Saline Solution Requirements in Hospital Settings. 28
  • 5.6 Impact Analysis: 29

6. US Physiological Saline Market - Market Analysis 30

  • 6.1 US Physiological Saline Market Revenue (US$ Mn), 2020 - 2030. 30

7. US Physiological Saline Market - Revenue and Forecast to 2030 - by Type 32

  • 7.1 Overview. 32
  • 7.2 US Physiological Saline Market Revenue Share, by Type 2022 & 2030 (%) 32
  • 7.3 Normal Saline. 33
    • 7.3.1 Overview. 33
    • 7.3.2 Normal Saline: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 33
  • 7.4 Hypertonic Saline. 35
    • 7.4.1 Overview. 35
    • 7.4.2 Hypertonic Saline: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 35
  • 7.5 Hypotonic Saline. 37
    • 7.5.1 Overview. 37
    • 7.5.2 Hypotonic Saline: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 37
  • 7.6 Balanced Saline Solution. 39
    • 7.6.1 Overview. 39
    • 7.6.2 Balanced Saline Solution: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 39

8. US Physiological Saline Market - Revenue and Forecast to 2030 - by Packaging Type 41

  • 8.1 Overview. 41
  • 8.2 US Physiological Saline Market Revenue Share, by Packaging Type 2022 & 2030 (%) 41
  • 8.3 Flexible Bags. 42
    • 8.3.1 Overview. 42
    • 8.3.2 Flexible Bags: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 42
  • 8.4 Plastic Bottles. 44
    • 8.4.1 Overview. 44
    • 8.4.2 Plastic Bottles: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 44
  • 8.5 Glass Bottles. 46
    • 8.5.1 Overview. 46
    • 8.5.2 Glass Bottles: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 46

9. US Physiological Saline Market - Revenue and Forecast to 2030 - by Application 48

  • 9.1 Overview. 48
  • 9.2 US Physiological Saline Market Revenue Share, by Application 2022 & 2030 (%) 48
  • 9.3 Intravenous. 49
    • 9.3.1 Overview. 49
    • 9.3.2 Intravenous: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 49
  • 9.4 Ophthalmology. 51
    • 9.4.1 Overview. 51
    • 9.4.2 Ophthalmology: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 51
  • 9.5 Wound Care. 53
    • 9.5.1 Overview. 53
    • 9.5.2 Wound Care: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 53
  • 9.6 Endoscopy. 55
    • 9.6.1 Overview. 55
    • 9.6.2 Endoscopy: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 55
  • 9.7 Skin Abrasion. 56
    • 9.7.1 Overview. 56
    • 9.7.2 Skin Abrasion: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 56
  • 9.8 Others. 57
    • 9.8.1 Overview. 57
    • 9.8.2 Others: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 57

10. US Physiological Saline Market - Revenue and Forecast to 2030 - by Route of Administration 58

  • 10.1 Overview. 58
  • 10.2 US Physiological Saline Market Revenue Share, by Route of Administration 2022 & 2030 (%) 58
  • 10.3 Intravenous. 59
    • 10.3.1 Overview. 59
    • 10.3.2 Intravenous: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 59
  • 10.4 Topical 60
    • 10.4.1 Overview. 60
    • 10.4.2 Topical: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 60

11. US Physiological Saline Market - Revenue and Forecast to 2030 - by End User 62

  • 11.1 Overview. 62
  • 11.2 US Physiological Saline Market Revenue Share, by End User 2022 & 2030 (%) 62
  • 11.3 Hospitals. 63
    • 11.3.1 Overview. 63
    • 11.3.2 Hospitals: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 63
  • 11.4 Specialty Clinics. 64
    • 11.4.1 Overview. 64
    • 11.4.2 Specialty Clinics: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 64
  • 11.5 Ambulatory Surgical Centers. 65
    • 11.5.1 Overview. 65
    • 11.5.2 Ambulatory Surgical Centers: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 65
  • 11.6 Homecare. 66
    • 11.6.1 Overview. 66
    • 11.6.2 Homecare: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 66
  • 11.7 Others. 67
    • 11.7.1 Overview. 67
    • 11.7.2 Others: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 67

12. Company Profiles 68

  • 12.1 Fresenius Kabi AG. 68
    • 12.1.1 Key Facts. 68
    • 12.1.2 Business Description. 68
    • 12.1.3 Products and Services. 69
    • 12.1.4 Financial Overview. 69
    • 12.1.5 SWOT Analysis. 70
    • 12.1.6 Key Developments. 70
  • 12.2 Merck KGaA. 71
    • 12.2.1 Key Facts. 71
    • 12.2.2 Business Description. 71
    • 12.2.3 Products and Services. 72
    • 12.2.4 Financial Overview. 74
    • 12.2.5 SWOT Analysis. 77
    • 12.2.6 Key Developments. 77
  • 12.3 AdipoGen Life Sciences Inc. 78
    • 12.3.1 Key Facts. 78
    • 12.3.2 Business Description. 78
    • 12.3.3 Products and Services. 79
    • 12.3.4 Financial Overview. 82
    • 12.3.5 SWOT Analysis. 82
    • 12.3.6 Key Developments. 82
  • 12.4 Enzo Life Sciences Inc. 83
    • 12.4.1 Key Facts. 83
    • 12.4.2 Business Description. 83
    • 12.4.3 Products and Services. 84
    • 12.4.4 Financial Overview. 86
    • 12.4.5 SWOT Analysis. 87
    • 12.4.6 Key Developments. 87
  • 12.5 ICU Medical Inc. 88
    • 12.5.1 Key Facts. 88
    • 12.5.2 Business Description. 88
    • 12.5.3 Products and Services. 89
    • 12.5.4 Financial Overview. 90
    • 12.5.5 SWOT Analysis. 92
    • 12.5.6 Key Developments. 93
  • 12.6 Grifols SA. 94
    • 12.6.1 Key Facts. 94
    • 12.6.2 Business Description. 94
    • 12.6.3 Products and Services. 95
    • 12.6.4 Financial Overview. 97
    • 12.6.5 SWOT Analysis. 99
    • 12.6.6 Key Developments. 100
  • 12.7 Geno Technology Inc. 101
    • 12.7.1 Key Facts. 101
    • 12.7.2 Business Description. 101
    • 12.7.3 Products and Services. 102
    • 12.7.4 Financial Overview. 105
    • 12.7.5 SWOT Analysis. 105
    • 12.7.6 Key Developments. 106
  • 12.8 B Braun Medical Inc. 107
    • 12.8.1 Key Facts. 107
    • 12.8.2 Business Description. 107
    • 12.8.3 Products and Services. 108
    • 12.8.4 Financial Overview. 111
    • 12.8.5 SWOT Analysis. 111
    • 12.8.6 Key Developments. 112
  • 12.9 Pfizer Inc. 113
    • 12.9.1 Key Facts. 113
    • 12.9.2 Business Description. 113
    • 12.9.3 Products and Services. 114
    • 12.9.4 Financial Overview. 115
    • 12.9.5 SWOT Analysis. 117
    • 12.9.6 Key Developments. 118
  • 12.10 Ward's Science. 119
    • 12.10.1 Key Facts. 119
    • 12.10.2 Business Description. 119
    • 12.10.3 Products and Services. 120
    • 12.10.4 Financial Overview. 127
    • 12.10.5 SWOT Analysis. 128
    • 12.10.6 Key Developments. 128

13. Appendix 129

  • 13.1 About Us. 129
  • 13.2 Glossary of Terms. 131

List Of Tables

  • Table 1. US Physiological Saline Market Segmentation. 14
  • Table 2. Normal Saline 2020-2030 (US$ Mn) 34
  • Table 3. Normal Saline 2020-2030 (US$ Mn) 36
  • Table 4. Hypotonic Saline 2020-2030 (US$ Mn) 38
  • Table 5. Balanced Saline Solution (BSS) 2020-2030 (US$ Mn) 40
  • Table 6. Flexible Bags 2020-2030 (US$ Mn) 43
  • Table 7. Plastic Bottles 2020-2030 (US$ Mn) 45
  • Table 8. Glass Bottles 2020-2030 (US$ Mn) 47
  • Table 9. Topical 2020-2030 (US$ Mn) 61
  • Table 10. Glossary of Terms, US Physiological Saline Market 131

List Of Figures

  • Figure 1. US Physiological Saline Market Segmentation, By Country. 15
  • Figure 2. Key Insights. 16
  • Figure 3. US - PEST Analysis. 22
  • Figure 4. US Physiological Saline Market - Key Industry Dynamics. 25
  • Figure 5. Impact Analysis of Drivers and Restraints. 29
  • Figure 6. US Physiological Saline Market Revenue (US$ Mn), 2020 - 2030. 31
  • Figure 7. US Physiological Saline Market Revenue Share, by Type 2022 & 2030 (%) 32
  • Figure 8. Normal Saline: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 34
  • Figure 9. Hypertonic Saline: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 36
  • Figure 10. Hypertonic Saline: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 38
  • Figure 11. Balanced Saline Solution: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 40
  • Figure 12. US Physiological Saline Market Revenue Share, by Packaging Type 2022 & 2030 (%) 41
  • Figure 13. Flexible Bags: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 43
  • Figure 14. Plastic Bottles: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 45
  • Figure 15. Glass Bottles: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 47
  • Figure 16. US Physiological Saline Market Revenue Share, by Application 2022 & 2030 (%) 48
  • Figure 17. Intravenous: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 50
  • Figure 18. Ophthalmology: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 52
  • Figure 19. Wound Care: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 54
  • Figure 20. Endoscopy: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 55
  • Figure 21. Skin Abrasion: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 56
  • Figure 22. Others: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 57
  • Figure 23. US Physiological Saline Market Revenue Share, by Route of Administration 2022 & 2030 (%) 58
  • Figure 24. Intravenous: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 59
  • Figure 25. Topical: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 60
  • Figure 26. US Physiological Saline Market Revenue Share, by End User 2022 & 2030 (%) 62
  • Figure 27. Hospitals: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 63
  • Figure 28. Specialty Clinics: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 64
  • Figure 29. Ambulatory Surgical Centers: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 65
  • Figure 30. Homecare: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 66
  • Figure 31. Others: US Physiological Saline Market - Revenue and Forecast to 2030 (US$ Million) 67